The uniquely lethal nature of the tobacco industry’s products,1 the industry’s environmental impact2 and its incompatibility with human rights3 make the takeover of Vectura, a pharmaceutical company focused on inhaler technology, by tobacco giant Philip Morris International (PMI), extremely unwelcome. The idea that a company which, based on its market share and the global death toll, kills more than a million people every year4 should be allowed to expand into the delivery of healthcare has been widely condemned, including by the British Thoracic Society (BTS) (box 1), the European Respiratory Society5 and the US COPD Foundation, as well as the American Lung Association and American Thoracic Society who referred to the move as ‘reprehensible’.6 Box 1 ### British Thoracic Society Statement on Philip Morris International’s takeover of Vectura Vectura, a company that for over 20 years has worked to treat lung disease, is now part of the tobacco industry. This is inappropriate, unethical and should have been prevented. The society’s policy in relation to the tobacco industry14 remains clear :

中文翻译：

---

Vectura 和菲利普莫里斯：豹子没有改变它的位置

烟草业产品的独特致命性1、该行业对环境的影响2及其与人权的不相容性3使得烟草巨头菲利普莫里斯国际公司(PMI)收购专注于吸入器技术的制药公司Vectura极为不受欢迎。一家基于其市场份额和全球死亡人数，每年造成超过 100 万人死亡 4 的公司应该被允许扩展到提供医疗保健服务的想法已受到广泛谴责，包括英国胸科学会 (BTS) （方框 1）、欧洲呼吸学会 5 和美国慢性阻塞性肺病基金会，以及美国肺脏协会和美国胸科学会，他们认为此举是“应受谴责的”。6 方框1 ### 英国胸科学会关于菲利普莫里斯国际公司收购Vectura Vectura 的声明，这家公司20 多年来一直致力于治疗肺部疾病，现在已成为烟草业的一部分。这是不恰当的、不道德的，应该被阻止。社会对烟草业的政策 14 仍然很明确：